Abstract
From the perspective of utilization management, surgical and cytopathology are fundamentally different from laboratory-based testing in that billed revenues include both a technical component (part A) and a professional component for physician services (part B). Due to the professional billing component under fee for service, there can be a disincentive for anatomic pathologists to engage in utilization management which could impact practice revenues. Unlike clinical laboratory testing where clinicians are often leaders in utilization management initiatives, in most cases clinicians are unaware of mis-utilization of anatomic pathology services. Consequently there are relatively few published studies concerning utilization management in anatomic pathology or cytopathology. Nonetheless a review of the literature combined with personal experiences reveals a number of potential utilization management opportunities that can be successfully implemented in anatomic pathology.
Beyond the impact of utilization management on practice revenues, there are also significant medical-legal issues that create barriers to utilization management in anatomic pathology. Failure to adhere to the standard of care in the evaluation of anatomic pathology specimens may result in lawsuits for negligence with significant adverse consequences for the pathologist. Looking to the future, the transition from fee-for-service reimbursement to bundled payments for entire episodes of care (or entire populations) will create new incentives for improving utilization management in anatomic pathology. To help guide this effort, it will be important for pathology professional societies such as the College of American Pathologists to develop appropriate standards of care for the evaluation of anatomic pathology specimens to assist practicing pathologists in establishing a utilization management program in their practices.
Portions of this chapter were derived from a recent review by the author published in Clin Chim Acta. 2014;427:183–7.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wilson M, Storfa A. Physician productivity: issues and controversies. Am J Clin Pathol. 2015;143:6–9.
Volk E. College of American Pathologists Advocacy: the effort to preserve fair payment. Arch Pathol Lab Med. 2015;139:161–2.
Seegmiller A, Kim A, Mosse C, Levy M, Thompson M, et al. Optimizing personalized bone marrow testing using an evidence-based, interdisciplinary team approach. Am J Clin Pathol. 2013;140:643–50.
Kovach A, DeLelys M, Kelliher A, Dillon L, Hasserjian R, Ferry J, Preffer F, Sohani A. Diagnostic utility of cerebrospinal fluid flow cytometry in patients with and without prior hematologic malignancy. Am J Hematol. 2014;81:978–84.
Eltoum I, Robertson J. Impact of expected changes in national Papanicolaou test volume on the cytotechnology labor market. Am J Clin Pathol. 2007;128:665–70.
Zarbo R, Nakhleh R. Surgical pathology specimens for gross examination only and exempt from submission. Arch Pathol Lab Med. 1999;123:133–9.
Fitzgibbons P, Clearly K. CAP offers recommendations on selecting surgical specimens for examination. CAP Today. 1996;40.
Goss G. Money saving tips for anatomic pathology. Advance for Laboratory Administrators. 2001.
Chitkara Y. Upfront special staining for Helicobacter pylori in gastric biopsy specimens is not indicated. Am J Clin Pathol. 2015;143:84–8.
Hartman D, Owens S. Are routine ancillary stains required to diagnose Helicobacter infection in gastric biopsy specimens. An institutional quality assurance review. Am J Clin Pathol. 2012;137:255–60.
Mitchell J. Linkages between utilization of prostate surgical pathology services and physician self-referral. Medicare Medicaid Res Rev. 2012;2:E1–18.
Ballentine C, Albertsen P, Barry M, Etzioni R, Freedland S. Early detection of prostate cancer: AUA guideline. https://www.auanet.org/education/guidelines/prostate-cancer-detection.cfm. Accessed 3 Feb 2015.
Taxy J. Frozen section and the pathologist. Arch Pathol Lab Med. 2009;133:1135–8.
Prey M, Martin S. Guidelines for practical utilization of frozen sections. Arch Surg. 1989;124:331–5.
Jorns J, Daignault S, Sabel M, Wu A. Is intraoperative frozen section analysis of reexcision specimens of value in preventing reoperation in breast-conserving therapy. Am J Clin Pathol. 2014;142:601–8.
Sullivan W. Why “choosing wisely” wont protect you in a lawsuit. Medscape, http://www.medscape.com/viewarticle/837399.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Lewandrowski, K. (2017). Utilization Management in Anatomic Pathology. In: Lewandrowski, K., Sluss, P. (eds) Utilization Management in the Clinical Laboratory and Other Ancillary Services. Springer, Cham. https://doi.org/10.1007/978-3-319-34199-6_16
Download citation
DOI: https://doi.org/10.1007/978-3-319-34199-6_16
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-34197-2
Online ISBN: 978-3-319-34199-6
eBook Packages: MedicineMedicine (R0)